Dec 1, 2025 Log in

其他

Aipass Biotech Q4 2025 Financial Report

Citation-Grade Primary-source linked Schema.org verified NQ 63 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Dec 1, 2025 9:00 AM ・ Updated Jun 1, 2026 12:21 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Aipass Biotech (Company Code: 6918) reported strong financial results for Q4 2025, with basic EPS of NT.16, revenue of NT36 million, and net profit after tax of NT70 million.

Aipass Biotech (Company Code: 6918) reported strong financial results for Q4 2025, with basic EPS of NT.16, revenue of NT36 million, and net profit after tax of NT70 million.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/financial/twse-fin-6918-2025Q4 Distributor: PR Times
Published: Dec 1, 2025

Company Code: 6918 Company Name: Aipass Biotech Co., Ltd. Industry: Biotechnology and Medical Care Year/Quarter: 2025 Q4 Basic Earnings Per Share: NT.16 Operating Revenue: NT36 million Net Profit After Tax: NT70 million

FACT BOX

Source: PR Times
Category: 其他

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Dec 1, 2025 9:00 AM — Distributor PR Times
Collected　Apr 7, 2026 8:00 AM
AI structured & analyzed　Apr 8, 2026 12:21 AM
Desk-reviewed & published　Dec 1, 2025 9:00 AM

FAQ

What are the key facts in this article?

Aipass Biotech (Company Code: 6918) reported strong financial results for Q4 2025, with basic EPS of NT.16, revenue of NT36 million, and net profit after tax of NT70 million.

Where is the primary source?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-6918-2025Q4

When was it published?

Dec 1, 2025

Cite this article — HOW TO CITE

Washin AI News Desk“Aipass Biotech Q4 2025 Financial Report”AI News by Washin Village（和心村）, Dec 1, 2025. https://aeo.washinmura.jp/ai/%E6%84%9B%E6%B4%BE%E5%8F%B8%E7%94%9F%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/en/news/2025-12-01-aipass-biotech-q4-2025-financial-report

AI CRAWLER ACTIVITY

as of Jul 17, 2026

AI crawler visits to this article (cumulative)121 bots

Site-wide cumulative

Applebot

bot_visits_summary

4139k

last Jul 17, 2026

ClaudeBot

bot_visits_summary

3026k

last Jul 17, 2026

GPTBot

bot_visits_summary

2585k

last Jul 17, 2026

Bingbot

bot_visits_summary

2450k

last Jul 17, 2026

Meta AI

bot_visits_summary

1011k

last Jul 17, 2026

Google AI

bot_visits_summary

687k

last Jul 17, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 愛派司生技股份有限公司 Back to newsroom (13)

Copied